Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pajak, T.F
344  Ergebnisse:
Personensuche X
?
1

25:

Cooper, J.S. ; Pajak, T.F. ; Forastiere, A.A....
International Journal of Radiation Oncology*Biology*Physics.  66 (2006)  3 - p. S14-S15 , 2006
Link: https://doi.org/10.1016/..
 
?
2

Long Term Outcomes of RTOG 90–03: A Comparison of Hyperfrac..:

Trotti, A. ; Fu, K.K. ; Pajak, T.F....
International Journal of Radiation Oncology*Biology*Physics.  63 (2005)  - p. S70-S71 , 2005
Link: https://doi.org/10.1016/..
 
?
3

The TAME Risk Classification System: Acute Toxicity Burden ..:

Pajak, T.F. ; Trotti, A. ; Gwede, C.K....
International Journal of Radiation Oncology*Biology*Physics.  63 (2005)  - p. S131 , 2005
Link: https://doi.org/10.1016/..
 
?
4

Defining risk levels in locally advanced head and neck canc..:

Bernier, Jacques ; Cooper, Jay S. ; Pajak, T. F....
Head & Neck.  27 (2005)  10 - p. 843-850 , 2005
Link: https://doi.org/10.1002/..
 
?
5

Patterns of failure for resected advanced head & neck cance..:

Cooper, J.S ; Pajak, T.F ; Forastiere, A.A...
International Journal of Radiation Oncology*Biology*Physics.  54 (2002)  2 - p. 2 , 2002
Link: https://doi.org/10.1016/..
 
?
6

A Radiation Therapy Oncology Group (RTOG) phase III randomi..:

Fu, K.K ; Pajak, T.F ; Trotti, A...
Cancer/Radiothérapie.  5 (2001)  1 - p. 95-96 , 2001
Link: https://doi.org/10.1016/..
 
?
7

Microvessel density (mvd)≥60 does not predict for outcome i..:

Calvin, D.P. ; Hammond, M.E.H. ; Pajak, T.F....
International Journal of Radiation Oncology*Biology*Physics.  51 (2001)  3 - p. 41 , 2001
Link: https://doi.org/10.1016/..
 
?
8

1 A radiation therapy oncology group (RTOG) phase III rando..:

Fu, K.K. ; Pajak, T.F. ; Trotti, A....
International Journal of Radiation Oncology*Biology*Physics.  45 (1999)  3 - p. 145 , 1999
Link: https://doi.org/10.1016/..
 
?
9

Anal sphincter conservation for patients with adenocarcinom..:

Russell, A.H. ; Pajak, T.F. ; Rosenberg, P.J....
International Journal of Radiation Oncology*Biology*Physics.  42 (1998)  1 - p. 162 , 1998
Link: https://doi.org/10.1016/..
 
?
10

1007 The need for central pathology tumor grading in prosta..:

Winter, K. ; Grignon, D. ; Pajak, T.F....
International Journal of Radiation Oncology*Biology*Physics.  39 (1997)  2 - p. 219 , 1997
Link: https://doi.org/10.1016/..
 
?
11

p53 Status and Prognosis of Locally Advanced Prostatic Aden..:

Grignon, D. J. ; Sarkar, F. H. ; Forman, J. D....
JNCI Journal of the National Cancer Institute.  89 (1997)  2 - p. 158-165 , 1997
Link: https://doi.org/10.1093/..
 
?
12

Toxicity of Isotretinoin in a Chemoprevention Trial to Prev..:

BENNER, S. E. ; PAJAK, T. F. ; STETZ, J....
JNCI Journal of the National Cancer Institute.  86 (1994)  23 - p. 1799-1801 , 1994
Link: https://doi.org/10.1093/..
 
?
13

Late effects of hyperfractionated radiotherapy for advanced..:

Fu, K.K. ; Pajak, T.F. ; Marcial, V.A....
International Journal of Radiation Oncology*Biology*Physics.  30 (1994)  - p. 157-158 , 1994
Link: https://doi.org/10.1016/..
 
?
14

Prevention of Second Primary Tumors With Isotretinoin in Pa..:

Benner, S. E. ; Pajak, T. F. ; Lippman, S. M...
JNCI Journal of the National Cancer Institute.  86 (1994)  2 - p. 140-141 , 1994
Link: https://doi.org/10.1093/..
 
?
15

RTOG clinical trials with etanidazole:

Wasserman, T.H. ; Pajak, T.F. ; Lee, D-J...
European Journal of Cancer.  29 (1993)  - p. S19 , 1993
Link: https://doi.org/10.1016/..
 
1-15